Recent Developments: Securities Fraud Actions Against Life Sciences Companies

Presented by Dechert’s Trials, Investigations and Securities Team

Securities class action litigation remained at a steady high in 2020, and life sciences companies were, once again, popular targets of such lawsuits. Presenters discussed the most recent edition of Dechert's annual survey, in which we analyzed trends identified in last year’s filings and decisions so that prudent life sciences companies can continue to take heed of the results and reduce their risk of being targets of a securities fraud claim.

Details
Thursday, March 4, 2021
12:00 p.m. - 12:30 p.m. EST
9:00 p.m. - 9:30 p.m. PST

Continuing Legal Education
Applications for CLE credit in California, Connecticut, Illinois and New York were approved. If you are seeking information on CLE credits for this program, please contact Nikki Bazemore.